Hypomethylation of thymosin ß4 promoter is associated with glucocorticoid therapy in patients with acute-on-chronic hepatitis B-induced liver failure.

Wang, He; Qian, Yu; Wang, Jing-Wen; Fang, Yu; Fan, Yu-Chen; Liu, Hui-Hui; Wang, Kai

Wang, He; Qian, Yu; Wang, Jing-Wen; Fang, Yu; Fan, Yu-Chen; Liu, Hui-Hui; Wang, Kai.

Affiliation

Wang H; Department of Hepatology, Qilu Hospital of Shandong University, Jinan 250012, China.
Qian Y; Department of Hepatology, Qingdao Sixth People's Hospital, Qingdao 266000, China.
Wang JW; Department of Hepatology, Qilu Hospital of Shandong University, Jinan 250012, China.
Fang Y; Department of Hepatology, Qilu Hospital of Shandong University, Jinan 250012, China.
Fan YC; Department of Hepatology, Qilu Hospital of Shandong University, Jinan 250012, China.
Liu HH; Department of Hepatology, Qilu Hospital of Shandong University, Jinan 250012, China.
Wang K; Institute of Hepatology, Shandong University, Jinan 250012, China.

Int Health ; 15(1): 19-29, 2023 01 03.

Article de En | MEDLINE | ID: mdl-35150577

Sujet(s)
Mots clés

acute-on-chronic hepatitis B liver failure; glucocorticoid therapy; methylation; thymosin ß4 promoter

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Hépatite B chronique / Maladie du foie en phase terminale / Insuffisance hépatique aigüe sur chronique Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Int Health Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google